(6S,7S)-6,7-Dimethyl-6,7-dihydro-[1,4]dioxocino[6,5-b:7,8-b']dipyridine

Catalog No. :
ACPQLI594
CAS No. :
175411-93-5
Molecular Formula :
C14H14N2O2
Molecular Weight :
242.28

IUPAC Name:(6S,7S)-6,7-dimethyl-6,7-dihydro-[1,4]dioxocino[6,5-b:7,8-b']dipyridine

(6S,7S)-6,7-Dimethyl-6,7-dihydro-[1,4]dioxocino[6,5-b:7,8-b']dipyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg99%$146.00Login to see priceIn stockInquiry
100mg99%$231.00Login to see priceIn stockIn stock
250mg99%$381.00Login to see priceIn stockIn stock
1g99%$1017.00Login to see priceIn stockIn stock

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(6S,7S)-6,7-Dimethyl-6,7-dihydro-[1,4]dioxocino[6,5-b:7,8-b']dipyridine
IUPAC Name(6S,7S)-6,7-dimethyl-6,7-dihydro-[1,4]dioxocino[6,5-b:7,8-b']dipyridine
Molecular FormulaC14H14N2O2
Molecular Weight242.28
SMILESC[C@H]1[C@H](C)OC2=CC=CN=C2C3=NC=CC=C3O1
InChI KeyAYOIRZGVWHHWMP-UWVGGRQHSA-N
Synonym(Ra,S,S)-C2-ACBP, 99%, ee: 99%;(RA,S,S)-C2-ACBP, EE;[1,4]Dioxocino[6,5-b:7,8-b']dipyridine, 6,7-dihydro-6,7-dimethyl-, (6S,7S)- (9CI);(6S,7S)-6,7-Dimethyl-6,7-dihydro-[1,4]dioxocino[6,5-b:7,8-b']dipyridine;(Rax,S,S)-C2-ACBP
CAS No.175411-93-5
PubChem CID163201297

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACPQLI594 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPQLI594 route product structure diagram
    ACPQLI594175411-93-5 In Stock
Inquiry

2. ACPQLI594 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPQLI594 route product structure diagram
    ACPQLI594175411-93-5 In Stock
Inquiry

Comments (0)